Omada Health has accomplished a rare feat in the crowded world of digital health hopefuls: it's backed up lofty claims with actual results, helping the company score federal government reimbursements for its high-tech diabetes prevention program. Now, Omada is taking on some major biopharma talent as it heads into 2017 with the goal of becoming a go-to "digital therapeutics" option.
Omada has hired former Sanofi chief medical officer (CMO) Dr. Paul Chew to serve as the company's new CMO and Tom Schoenherr, who helped lead genomic sequencing upstart Counsyl to the $100 million threshold, as its new chief commercial officer (CCO). The firm's also snapped up Dr. Carolyn Jasik of the University of California at San Francisco to serve as medical director and industry vet Rob Guigley (formerly of Counsyl and AstraZeneca) as the VP of health plan sales.
Read More: http://fortune.com/2017/01/06/exclusive-omada-health-hires-sanofi-counsyl/